117 related articles for article (PubMed ID: 11423595)
21. Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer.
Fanti L; Ieri R; Mezzi G; Testoni PA; Passaretti S; Guslandi M
J Clin Gastroenterol; 2001 Jan; 32(1):45-8. PubMed ID: 11154169
[TBL] [Abstract][Full Text] [Related]
22. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
23. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
Suzuki M; Kitahora T; Nagahashi S; Suzuki H; Mori M; Hibi T; Ishii H
J Clin Gastroenterol; 1998; 27 Suppl 1():S183-6. PubMed ID: 9872519
[TBL] [Abstract][Full Text] [Related]
24. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
[TBL] [Abstract][Full Text] [Related]
25. Can the C-14 urea breath test replace follow-up endoscopic biopsies in patients treated for Helicobacter pylori infection?
Ahuja V; Bal CS; Sharma MP
Clin Nucl Med; 1998 Dec; 23(12):815-9. PubMed ID: 9858292
[TBL] [Abstract][Full Text] [Related]
26. In treatment of active duodenal ulcer and Helicobacter pylori eradication.
Yukselen V; Yasa MH; Karaoglu AO
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccvi-cccviii. PubMed ID: 15244210
[TBL] [Abstract][Full Text] [Related]
27. One-week once-daily triple therapy for Helicobacter pylori--a pilot study.
Chu KM; Kwok KF; Law SY; Wong J
Hepatogastroenterology; 2000; 47(36):1624-6. PubMed ID: 11149018
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori and gastric or duodenal ulcer.
Prescrire Int; 2016 Jan; 25(167):18-23. PubMed ID: 26942258
[TBL] [Abstract][Full Text] [Related]
29. Eradication of Helicobacter pylori with lansoprazole, roxithromycin and metronidazole--an open pilot study.
Pohle T; Stoll R; Kirchner T; Heep M; Lehn N; Bock H; Domschke W
Aliment Pharmacol Ther; 1998 Dec; 12(12):1273-8. PubMed ID: 9882038
[TBL] [Abstract][Full Text] [Related]
30. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
[TBL] [Abstract][Full Text] [Related]
31. Dual versus triple therapy in eradication of Helicobacter pylori.
Ohlin B; Cederberg A; Kjellin T; Kullman E; Melén K; von Holstein CS; Thoring M
Hepatogastroenterology; 2002; 49(43):172-5. PubMed ID: 11941946
[TBL] [Abstract][Full Text] [Related]
32. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
de Boer WA; van Etten RJ; Schade RW; Ouwehand ME; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 1996 Sep; 91(9):1778-82. PubMed ID: 8792697
[TBL] [Abstract][Full Text] [Related]
33. One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
Sito E; Konturek PC; Bielański W; Kwiecień N; Konturek SJ; Baniukiewicz A; Jedynak M; Gabryelewicz A; Hahn EG
J Physiol Pharmacol; 1996 Mar; 47(1):221-8. PubMed ID: 8777303
[TBL] [Abstract][Full Text] [Related]
34. [Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Labenz J; Tillenburg B; Peitz U; Köhl H; Becker T; Stolte M; Börsch G
Dtsch Med Wochenschr; 1996 Jan; 121(1-2):3-7; discussion 7-8. PubMed ID: 8565802
[TBL] [Abstract][Full Text] [Related]
35. A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Yang JC; Yang KC; Hsu CT; Wang CS; Kuo CF; Wang TH
J Microbiol Immunol Infect; 1999 Mar; 32(1):1-8. PubMed ID: 11561564
[TBL] [Abstract][Full Text] [Related]
36. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G
Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
[TBL] [Abstract][Full Text] [Related]
38. Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan.
Suzuki J; Mine T; Kobayasi I; Fujita T
Helicobacter; 1998 Mar; 3(1):59-63. PubMed ID: 9546120
[TBL] [Abstract][Full Text] [Related]
39. [Erradicating treatment of Helicobacter pylori with lansoprazole and amoxicillin in duodenal ulcer patients].
Gisbert JP; Boixeda D; Alvarez Baleriola I; Martín de Argila C; Bermejo F; Aller R
Rev Clin Esp; 1996 Sep; 196(9):588-93. PubMed ID: 8966319
[TBL] [Abstract][Full Text] [Related]
40. The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.
Sivri B; Simsek I; Hulagu S; Kadayifci A; Tozun N; Akarsu M; Uraz S; Savas MC; Koruk M; Bozbas A
Curr Med Res Opin; 2004 Aug; 20(8):1301-7. PubMed ID: 15324533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]